We're Making Connections
King is committed to improving and protecting the quality of life through an active program of external business development with the following strategic focus:
- In-licensing of new innovative exclusive products, including new chemical entities, in late-stage development (Phase II and III);
- Acquisition of approved branded products with strong growth potential;
- Partnerships, strategic alliances and research and development collaborations involving early-stage compounds.
The focus of our external development activities are in the following areas:
- Cardiovascular and Metabolic Disorders
- Neuroscience, with a focus on Pain Management
- Hospital Products used in the Periopertive Setting
- Acute Care Products
- Drug Delivery Technologies
The Company also considers compelling strategic opportunities related to other therapeutic categories which compliment our core commercial, R&D and manufacturing capabilities. If you are interested in presenting a business development opportunity to King, please submit a proposal below.